These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9989740)

  • 21. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of multiple sclerosis with interferons].
    Nogales-Gaete J; Arriagada C
    Rev Med Chil; 1996 May; 124(5):597-604. PubMed ID: 9035514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferons in the treatment of multiple sclerosis: errors and misrepresentations.
    Herndon RM
    Arch Neurol; 2000 Mar; 57(3):426-7. PubMed ID: 10714676
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interferon-beta in treatment of relapsing multiple sclerosis].
    Hartung HP; Hohlfeld R
    Nervenarzt; 1994 Feb; 65(2):139-45. PubMed ID: 8164769
    [No Abstract]   [Full Text] [Related]  

  • 26. Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study.
    Comi G; Barkhof F; Durelli L; Edan G; Fernandez O; Filippi M; Hartung HP; Hommes OR; Seeldrayers P; Soelberg-Sorensen P
    Mult Scler; 1995; 1 Suppl 1():S24-7. PubMed ID: 9345394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of multiple sclerosis in children: a European view.
    Ghezzi A; Banwell B; Boyko A; Amato MP; Anlar B; Blinkenberg M; Boon M; Filippi M; Jozwiak S; Ketelslegers I; Kornek B; Lim M; Lindstrom E; Nadj C; Neuteboom R; Rocca MA; Rostasy K; Tardieu M; Wassmer E; Catsman-Berrevoets C; Hintzen R
    Mult Scler; 2010 Oct; 16(10):1258-67. PubMed ID: 20685764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon beta in multiple sclerosis.
    Arnason BG
    Neurology; 1993 Apr; 43(4):641-3. PubMed ID: 8469315
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
    Lancet; 1998 Nov; 352(9139):1498-504. PubMed ID: 9820297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon beta-1a and beta-1b for treatment of multiple sclerosis.
    Benatar M
    Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424021
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon beta in multiple sclerosis.
    Napier JC
    Lancet; 1999 Aug; 354(9177):512; author reply 512-3. PubMed ID: 10465197
    [No Abstract]   [Full Text] [Related]  

  • 32. [Management of the patient with multiple sclerosis].
    Hébel A
    Rev Infirm; 2004 Jan; (97):33-4. PubMed ID: 15027142
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon beta treatment for multiple sclerosis.
    Johnson KP; Panitch HS
    Lancet; 1999 Feb; 353(9151):494; author reply 497-8. PubMed ID: 9989738
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferon beta in multiple sclerosis. Interferon beta reduces overall relapse rate by one third.
    Napier JC
    BMJ; 1997 Feb; 314(7080):601. PubMed ID: 9055729
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple sclerosis: early management.
    Zajicek J
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):137-40. PubMed ID: 9166373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon-beta treatment of progressive disseminated sclerosis. Is it possibly without effect?].
    Foldspang A
    Ugeskr Laeger; 1999 Aug; 161(31):4418-21. PubMed ID: 10487112
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current therapy of multiple sclerosis].
    Vass K; Schmied M
    Wien Med Wochenschr; 1996; 146(19-20):514-9. PubMed ID: 9082651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More immunotherapy for multiple sclerosis.
    Hughes RA; Sharrack B
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):239-41. PubMed ID: 8795592
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interferon-beta in the treatment of multiple sclerosis].
    Panelius M; Salonen R; Ruutiainen J
    Duodecim; 1995; 111(7):587-9. PubMed ID: 8681813
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial.
    Fernández O; Antiquëdad A; Arbizu T; Capdevíla A; de Castro P; Correa de Sa JC; García-Merino JA; Izquierdo G; Magalhaes A; Montalbán X
    Mult Scler; 1995; 1 Suppl 1():S67-9. PubMed ID: 9345404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.